UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer

Acta pharmaceutica Sinica. B, 2022-06, Vol.12 (6), p.2845-2858

2022

Volltextzugriff (PDF)

A novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal models

Acta pharmaceutica Sinica. B, 2020-02, Vol.10 (2), p.276-288

2020

Volltextzugriff (PDF)

S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung

Acta pharmaceutica Sinica. B, 2023-03, Vol.13 (3), p.1110-1127

2023

Volltextzugriff (PDF)

Author correction to “YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer” [Acta Pharmaceutica Sinica B 12 (2022) 2845–2858]

Acta pharmaceutica Sinica. B, 2023-07, Vol.13 (7), p.3178-3179

2023

Volltextzugriff (PDF)

Discovery and druggability evaluation of pyrrolamide-type GyrB/ParE inhibitor against drug-resistant bacterial infection

Acta pharmaceutica Sinica. B, 2023-12, Vol.13 (12), p.4945-4962

2023

Volltextzugriff (PDF)

Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as IDO1/TDO dual inhibitors

European journal of medicinal chemistry, 2020-02, Vol.188, p.111985, Article 111985

2020

Volltextzugriff (PDF)

Bioevaluation of a dual PI3K/HDAC inhibitor for the treatment of diffuse large B-cell lymphoma

Bioorganic & medicinal chemistry letters, 2022-09, Vol.71, p.128825-128825, Article 128825

2022

Volltextzugriff (PDF)

Identification of potential indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors by an FBG-based 3D QSAR pharmacophore model

Journal of molecular graphics & modelling, 2020-09, Vol.99, p.107628-107628, Article 107628

2020

Volltextzugriff (PDF)

Previously undescribed tetrahydroanthraquinones from Prismatomeris tetrandra (roxb.) K. Schum with antitumor cell proliferation activities

Phytochemistry (Oxford), 2024-04, Vol.220, p.113995-113995, Article 113995

2024

Volltextzugriff (PDF)

Discovery of novel indirubin-3′-monoxime derivatives as potent inhibitors against CDK2 and CDK9

Bioorganic & medicinal chemistry letters, 2015-06, Vol.25 (11), p.2447-2451

2015

Volltextzugriff (PDF)

Novel nitric oxide-releasing derivatives of pyranocarbazole as antitumor agents: Design, synthesis, biological evaluation, and nitric oxide release studies

European journal of medicinal chemistry, 2022-12, Vol.244, p.114832-114832, Article 114832

2022

Volltextzugriff (PDF)

Rational design and optimization of novel 4-methyl quinazoline derivatives as PI3K/HDAC dual inhibitors with benzamide as zinc binding moiety for the treatment of acute myeloid leukemia

European journal of medicinal chemistry, 2024-01, Vol.264, p.116015-116015, Article 116015

2024

Volltextzugriff (PDF)

Design, synthesis and biological evaluation of triaryl compounds as novel 20S proteasome inhibitors

Bioorganic & medicinal chemistry letters, 2020-11, Vol.30 (21), p.127508-127508, Article 127508

2020

Volltextzugriff (PDF)

Identification of N, C-capped di- and tripeptides as selective immunoproteasome inhibitors

European journal of medicinal chemistry, 2022-04, Vol.234, p.114252-114252, Article 114252

2022

Volltextzugriff (PDF)

Novel nitric oxide-releasing derivatives of triptolide as antitumor and anti-inflammatory agents: Design, synthesis, biological evaluation, and nitric oxide release studies

European journal of medicinal chemistry, 2020-03, Vol.190, p.112079, Article 112079

2020

Volltextzugriff (PDF)

Measuring strand discontinuity-directed mismatch repair in yeast Saccharomyces cerevisiae by cell-free nuclear extracts

Methods (San Diego, Calif.), 2009-05, Vol.48 (1), p.14-18

2009

Volltextzugriff (PDF)

Discovery of novel quinazoline-2,4(1H,3H)-dione derivatives as potent PARP-2 selective inhibitors

Bioorganic & medicinal chemistry, 2017-08, Vol.25 (15), p.4045-4054

2017

Volltextzugriff (PDF)

Design, synthesis and biological evaluation of novel indolin-2-ones as potent anticancer compounds

Bioorganic & medicinal chemistry letters, 2017-08, Vol.27 (15), p.3326-3331

2017

Volltextzugriff (PDF)

Involvement of Na/K-ATPase in hydrogen peroxide-induced activation of the Src/ERK pathway in LLC-PK1 cells

Free radical biology & medicine, 2014-06, Vol.71, p.415-426

2014

Volltextzugriff (PDF)

Nanos1 functions as a translational repressor in the Xenopus germline

Mechanisms of development, 2011-01, Vol.128 (1), p.153-163

2011

Volltextzugriff (PDF)

A Morphological identification cell cytotoxicity assay using cytoplasm-localized fluorescent probe (CLFP) to distinguish living and dead cells

Biochemical and biophysical research communications, 2017-01, Vol.482 (2), p.257-263

2017

Volltextzugriff (PDF)

Identification of 3, 4-disubstituted pyridine derivatives as novel CDK8 inhibitors

European journal of medicinal chemistry, 2021-11, Vol.223, p.113634, Article 113634

2021

Volltextzugriff (PDF)

Erratum: Author correction to "YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer" [Acta Pharmaceutica Sinica B 12 (2022) 2845-2858]

Acta pharmaceutica Sinica. B, 2023-07, Vol.13 (7), p.3178-3179

2023

Volltextzugriff (PDF)

Xenopus Nanos1 is required to preserve PGCs from endoderm specification

Developmental biology, 2011-08, Vol.356 (1), p.192-192

2011

Volltextzugriff (PDF)

Mycophenolic acid induces ATP-binding cassette transporter A1 (ABCA1) expression through the PPAR{gamma}-LXR{alpha}-ABCA1 pathway

Biochemical and biophysical research communications, 2011-11, Vol.414 (4)

2011

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(31)
Pharmacology & Pharmacy
(18)
Chemistry, Medicinal
(12)
Humans
(12)
Physical Sciences
(10)
Chemistry
(9)
Technology
(7)
Biochemistry & Molecular Biology
(6)
Chemistry, Organic
(6)
Molecular Structure
(6)
Structure-Activity Relationship
(6)
Animals
(5)
Cell Line, Tumor
(5)
Antineoplastic Agents - Chemical Synthesis
(4)
Cell Proliferation - Drug Effects
(4)
Female
(4)
Male
(4)
Antineoplastic Agents - Chemistry
(3)
Antitumor
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta.com
(44)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(33)
MEDLINE
(19)
Electronic Journals Library
(11)
IngentaConnect Journals
(8)
Journals@Ovid Ovid Full Text
(3)
SpringerLink Series
(1)

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer

A novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal models

S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung

Author correction to “YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer” [Acta Pharmaceutica Sinica B 12 (2022) 2845–2858]

Discovery and druggability evaluation of pyrrolamide-type GyrB/ParE inhibitor against drug-resistant bacterial infection

Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as IDO1/TDO dual inhibitors

Bioevaluation of a dual PI3K/HDAC inhibitor for the treatment of diffuse large B-cell lymphoma

Identification of potential indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors by an FBG-based 3D QSAR pharmacophore model

Previously undescribed tetrahydroanthraquinones from Prismatomeris tetrandra (roxb.) K. Schum with antitumor cell proliferation activities

Discovery of novel indirubin-3′-monoxime derivatives as potent inhibitors against CDK2 and CDK9

Novel nitric oxide-releasing derivatives of pyranocarbazole as antitumor agents: Design, synthesis, biological evaluation, and nitric oxide release studies

Rational design and optimization of novel 4-methyl quinazoline derivatives as PI3K/HDAC dual inhibitors with benzamide as zinc binding moiety for the treatment of acute myeloid leukemia

Design, synthesis and biological evaluation of triaryl compounds as novel 20S proteasome inhibitors

Identification of N, C-capped di- and tripeptides as selective immunoproteasome inhibitors

Novel nitric oxide-releasing derivatives of triptolide as antitumor and anti-inflammatory agents: Design, synthesis, biological evaluation, and nitric oxide release studies

Measuring strand discontinuity-directed mismatch repair in yeast Saccharomyces cerevisiae by cell-free nuclear extracts

Discovery of novel quinazoline-2,4(1H,3H)-dione derivatives as potent PARP-2 selective inhibitors

Design, synthesis and biological evaluation of novel indolin-2-ones as potent anticancer compounds

Involvement of Na/K-ATPase in hydrogen peroxide-induced activation of the Src/ERK pathway in LLC-PK1 cells

Nanos1 functions as a translational repressor in the Xenopus germline

A Morphological identification cell cytotoxicity assay using cytoplasm-localized fluorescent probe (CLFP) to distinguish living and dead cells

Identification of 3, 4-disubstituted pyridine derivatives as novel CDK8 inhibitors

Erratum: Author correction to "YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer" [Acta Pharmaceutica Sinica B 12 (2022) 2845-2858]

Xenopus Nanos1 is required to preserve PGCs from endoderm specification

Mycophenolic acid induces ATP-binding cassette transporter A1 (ABCA1) expression through the PPAR{gamma}-LXR{alpha}-ABCA1 pathway

Aktive Filter

Suchergebnisse filtern